3Bocsi J, Richter M, Hambsch J, et al. Transient Thl/Th2 disbalance indicates postoperative effusions and edema after cardiopulmonary bypass in children. Cytometry,2006, 69: 165-168.
5Chenoweth DE, Cooper SW,Hugli TE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. NEJM,1981,304: 497.
6Miller BE, Levy JH. The inflammat-ory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth, 1997,11 : 355-366.
7Miyaoka K, Iwase M, Suzuki R, et al. Clinical evaluation of circulating IL-6 and IL-10 levels after surgery-induced inflammation. J Surg Res, 2005,125: 144-150.
8Sundal E, Bertelletti D, Thymopentin treatment of rheumatoid arthritis. Arzneimittel-Forsehung, 1994, 44 : 1145-1149.
9Goldstein G, Conant MA, Beall G, et al. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 Cens/mm3: a double-blind placebo-controlled trial. JAIDS ,1995 ,8 : 279.
10Defraigne JO,Pincemail J,Larbuisson R,et al.Cytokine release and neutrophil activation are not prevented by heparin-coated circuit and approtinin administration[J].Ann Thorac Surg,2000,69(4):1084-1091.
